
Duc T. Duong
Examiner (ID: 7909, Phone: (571)272-3122 , Office: P/2467 )
| Most Active Art Unit | 2467 |
| Art Unit(s) | 2663, 2467, 2419, 2619, 2616 |
| Total Applications | 1201 |
| Issued Applications | 977 |
| Pending Applications | 137 |
| Abandoned Applications | 108 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12997629
[patent_doc_number] => 10022461
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-17
[patent_title] => Pyrrolo[2,3-C]pyridines as imaging agents for neurofibrilary tangles
[patent_app_type] => utility
[patent_app_number] => 15/724402
[patent_app_country] => US
[patent_app_date] => 2017-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 36736
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15724402
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/724402 | Pyrrolo[2,3-C]pyridines as imaging agents for neurofibrilary tangles | Oct 3, 2017 | Issued |
Array
(
[id] => 12466974
[patent_doc_number] => 09987567
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-06-05
[patent_title] => Cannabinoid extraction process and system
[patent_app_type] => utility
[patent_app_number] => 15/721344
[patent_app_country] => US
[patent_app_date] => 2017-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5561
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15721344
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/721344 | Cannabinoid extraction process and system | Sep 28, 2017 | Issued |
Array
(
[id] => 13763409
[patent_doc_number] => 10174039
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-08
[patent_title] => P2X
[patent_app_type] => utility
[patent_app_number] => 15/717185
[patent_app_country] => US
[patent_app_date] => 2017-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 32957
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15717185
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/717185 | P2X | Sep 26, 2017 | Issued |
Array
(
[id] => 15209569
[patent_doc_number] => 20190367471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => PROCESS FOR PREPARING CYCLIC ESTERS FROM ALPHA-HYDROXY ESTERS AND CATALYSTS USED THEREIN
[patent_app_type] => utility
[patent_app_number] => 16/336014
[patent_app_country] => US
[patent_app_date] => 2017-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16336014
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/336014 | Process for preparing cyclic esters from alpha-hydroxy esters and catalysts used therein | Sep 24, 2017 | Issued |
Array
(
[id] => 14581239
[patent_doc_number] => 20190218228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => ANTI-CANCER AGENTS AND PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/335378
[patent_app_country] => US
[patent_app_date] => 2017-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13897
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335378
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/335378 | Anti-cancer agents and preparation thereof | Sep 21, 2017 | Issued |
Array
(
[id] => 13856297
[patent_doc_number] => 10189857
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-29
[patent_title] => Positive allosteric modulators of the muscarinic acetylcholine receptor M
[patent_app_type] => utility
[patent_app_number] => 15/703451
[patent_app_country] => US
[patent_app_date] => 2017-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18672
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 207
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15703451
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/703451 | Positive allosteric modulators of the muscarinic acetylcholine receptor M | Sep 12, 2017 | Issued |
Array
(
[id] => 13236969
[patent_doc_number] => 10131675
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-20
[patent_title] => Tricyclic DLK inhibitors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/699095
[patent_app_country] => US
[patent_app_date] => 2017-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44304
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 853
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15699095
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/699095 | Tricyclic DLK inhibitors and uses thereof | Sep 7, 2017 | Issued |
Array
(
[id] => 12606462
[patent_doc_number] => 20180093984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-05
[patent_title] => N-ACYL AMINO ACID COMPOUNDS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 15/698435
[patent_app_country] => US
[patent_app_date] => 2017-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49537
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -54
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15698435
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/698435 | N-acyl amino acid compounds and methods of use | Sep 6, 2017 | Issued |
Array
(
[id] => 12857749
[patent_doc_number] => 20180177757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => ULTRAPURE TETRAHYDROCANNABINOL-11-OIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 15/698544
[patent_app_country] => US
[patent_app_date] => 2017-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18349
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15698544
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/698544 | Ultrapure tetrahydrocannabinol-11-oic acids | Sep 6, 2017 | Issued |
Array
(
[id] => 14926137
[patent_doc_number] => 20190298706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATORS FOR TREATMENT OF ANOREXIA NERVOSA AND BINGE EATING DISORDER
[patent_app_type] => utility
[patent_app_number] => 16/330469
[patent_app_country] => US
[patent_app_date] => 2017-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42740
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16330469
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/330469 | Nonselective metabotropic glutamate receptor activators for treatment of anorexia nervosa and binge eating disorder | Sep 5, 2017 | Issued |
Array
(
[id] => 15383839
[patent_doc_number] => 10533091
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-14
[patent_title] => Color conversion with solid matrix films
[patent_app_type] => utility
[patent_app_number] => 15/691776
[patent_app_country] => US
[patent_app_date] => 2017-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 115
[patent_no_of_words] => 46147
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 400
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15691776
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/691776 | Color conversion with solid matrix films | Aug 30, 2017 | Issued |
Array
(
[id] => 12239867
[patent_doc_number] => 20180072730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'NOVEL 7-SUBSTITUTED SULFONIMIDOYLPURINONE COMPOUNDS AND DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION'
[patent_app_type] => utility
[patent_app_number] => 15/689136
[patent_app_country] => US
[patent_app_date] => 2017-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 35802
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15689136
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/689136 | 7-substituted sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection | Aug 28, 2017 | Issued |
Array
(
[id] => 13887675
[patent_doc_number] => 10196378
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-05
[patent_title] => Inhibitors of BCR-ABL mutants and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/685707
[patent_app_country] => US
[patent_app_date] => 2017-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6137
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15685707
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/685707 | Inhibitors of BCR-ABL mutants and use thereof | Aug 23, 2017 | Issued |
Array
(
[id] => 15948601
[patent_doc_number] => 10662189
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-26
[patent_title] => PDE4 inhibitor
[patent_app_type] => utility
[patent_app_number] => 16/326976
[patent_app_country] => US
[patent_app_date] => 2017-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30998
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16326976
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/326976 | PDE4 inhibitor | Aug 21, 2017 | Issued |
Array
(
[id] => 16321240
[patent_doc_number] => 10781196
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-22
[patent_title] => Integrated process for direct saccharification and dehydration of intact biomass to furfurals
[patent_app_type] => utility
[patent_app_number] => 16/323000
[patent_app_country] => US
[patent_app_date] => 2017-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 12
[patent_no_of_words] => 7311
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16323000
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/323000 | Integrated process for direct saccharification and dehydration of intact biomass to furfurals | Aug 14, 2017 | Issued |
Array
(
[id] => 13761257
[patent_doc_number] => 10172957
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-08
[patent_title] => Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
[patent_app_type] => utility
[patent_app_number] => 15/675399
[patent_app_country] => US
[patent_app_date] => 2017-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 20
[patent_no_of_words] => 11830
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15675399
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/675399 | Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents | Aug 10, 2017 | Issued |
Array
(
[id] => 13079319
[patent_doc_number] => 10059717
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-28
[patent_title] => Urea compounds containing 3,4-dihydropyrimido[4,5-D]pyrimidin-2(1H)-one skeleton as protein kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/674023
[patent_app_country] => US
[patent_app_date] => 2017-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7893
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15674023
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/674023 | Urea compounds containing 3,4-dihydropyrimido[4,5-D]pyrimidin-2(1H)-one skeleton as protein kinase inhibitors | Aug 9, 2017 | Issued |
Array
(
[id] => 13222883
[patent_doc_number] => 10125206
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-11-13
[patent_title] => Non-halogenated flame retardant hindered amine light stabilizer impact modifiers
[patent_app_type] => utility
[patent_app_number] => 15/673500
[patent_app_country] => US
[patent_app_date] => 2017-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 36
[patent_no_of_words] => 10990
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15673500
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/673500 | Non-halogenated flame retardant hindered amine light stabilizer impact modifiers | Aug 9, 2017 | Issued |
Array
(
[id] => 12975598
[patent_doc_number] => 20170340616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => AMINOESTER DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 15/673710
[patent_app_country] => US
[patent_app_date] => 2017-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18932
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 640
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15673710
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/673710 | Aminoester derivatives | Aug 9, 2017 | Issued |
Array
(
[id] => 15944921
[patent_doc_number] => 10660334
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-26
[patent_title] => Fused bicyclic heterocycle derivatives as pesticides
[patent_app_type] => utility
[patent_app_number] => 16/325377
[patent_app_country] => US
[patent_app_date] => 2017-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35554
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 645
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16325377
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/325377 | Fused bicyclic heterocycle derivatives as pesticides | Aug 8, 2017 | Issued |